bioAffinity Technologies (BIAF) Return on Invested Capital (2022 - 2025)

bioAffinity Technologies has disclosed Return on Invested Capital across 4 years of filings, most recently posting 0.01% for Q4 2025.

• In Q4 2025, Return on Invested Capital rose 1.0% year-over-year to 0.01%; the TTM figure through Dec 2025 stood at 0.01% (up 1.0% YoY), while the FY2025 annual figure was 0.02%, changed 0.0% from the prior year.
• Return on Invested Capital rose to 0.01% in Q4 2025, from 0.03% in the prior quarter.
• Over the last five years, Return on Invested Capital for BIAF reached as high as 0.0% in Q4 2022 and fell as low as 0.89% in Q2 2025.
• The 4-year median for Return on Invested Capital is 0.01% (2024), against an average of 0.08%.
• The widest YoY moves for Return on Invested Capital: up 1 bps in 2025, down 88 bps in 2025.
• A 4-year view of Return on Invested Capital shows it stood at 0.0% in 2022, then tumbled by 363 bps to 0.01% in 2023, then plunged by 115 bps to 0.02% in 2024, then surged by 48 bps to 0.01% in 2025.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.01%, 0.03%, and 0.89% for Q4 2025, Q3 2025, and Q2 2025 respectively.